Drug Price/Access Standoff: Can Anyone Be Happy?
This article was originally published in Scrip
Executive Summary
Before stakeholders even gathered at a forum being convened on Nov. 20 at the Health and Human Services (HHS) headquarters near Capitol Hill in Washington to thrash out how best to ensure patients have access to affordable medicines while making sure industry can recoup its costs and reinvest in research and development, various groups already had drawn their battle lines.